Here, blocking tau spread by targeting neural activity related mechanisms of tau spread could be a promising target for attenuating AD progression21, especially in view of the limited clinical efficacy of anti-amyloid trials38,39. The gene discussed is MAPT; the disease is Alzheimer disease.